Millennium Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-921,330
Closed -$21.8M 4847
2023
Q4
$21.8M Buy
921,330
+777,926
+542% +$18.4M 0.01% 985
2023
Q3
$2.14M Sell
143,404
-1,300,590
-90% -$19.4M ﹤0.01% 2430
2023
Q2
$15.8M Sell
1,443,994
-1,505,062
-51% -$16.5M 0.01% 1147
2023
Q1
$25.7M Buy
2,949,056
+2,018,868
+217% +$17.6M 0.01% 823
2022
Q4
$5.83M Sell
930,188
-603,794
-39% -$3.79M ﹤0.01% 2015
2022
Q3
$5.37M Sell
1,533,982
-1,481,514
-49% -$5.19M ﹤0.01% 2146
2022
Q2
$8.9M Buy
3,015,496
+642,796
+27% +$1.9M 0.01% 1640
2022
Q1
$7.38M Buy
2,372,700
+301,913
+15% +$939K ﹤0.01% 1911
2021
Q4
$7M Buy
2,070,787
+112,134
+6% +$379K ﹤0.01% 1931
2021
Q3
$7.15M Sell
1,958,653
-144,159
-7% -$526K ﹤0.01% 1839
2021
Q2
$9.17M Buy
2,102,812
+49,033
+2% +$214K 0.01% 1511
2021
Q1
$9.32M Buy
2,053,779
+707,731
+53% +$3.21M 0.01% 1457
2020
Q4
$7.73M Sell
1,346,048
-336,355
-20% -$1.93M 0.01% 1575
2020
Q3
$12.2K Buy
1,682,403
+838,446
+99% +$6.07K 0.02% 825
2020
Q2
$2.95M Sell
843,957
-713,183
-46% -$2.49M ﹤0.01% 1774
2020
Q1
$2.31M Sell
1,557,140
-1,436,505
-48% -$2.13M 0.01% 1551
2019
Q4
$5.87M Sell
2,993,645
-730,152
-20% -$1.43M 0.01% 1443
2019
Q3
$19.1M Buy
3,723,797
+740,380
+25% +$3.79M 0.03% 641
2019
Q2
$21.4M Buy
2,983,417
+1,281,717
+75% +$9.18M 0.03% 631
2019
Q1
$22.6M Buy
1,701,700
+538,548
+46% +$7.15M 0.03% 640
2018
Q4
$9.15M Buy
1,163,152
+253,377
+28% +$1.99M 0.01% 1071
2018
Q3
$10.1M Sell
909,775
-258,857
-22% -$2.87M 0.01% 1187
2018
Q2
$15.7M Buy
1,168,632
+8,357
+0.7% +$112K 0.02% 936
2018
Q1
$15.1M Buy
1,160,275
+1,094,594
+1,667% +$14.2M 0.02% 1011
2017
Q4
$604K Sell
65,681
-1,637,443
-96% -$15.1M ﹤0.01% 2781
2017
Q3
$13.7M Buy
1,703,124
+1,277,226
+300% +$10.3M 0.02% 969
2017
Q2
$2.45M Buy
425,898
+387,783
+1,017% +$2.23M ﹤0.01% 1787
2017
Q1
$164K Buy
+38,115
New +$164K ﹤0.01% 3023